Ayşe Arzu YORGANCIOĞLU, Cemal CİNGİ, Bilun GEMİCİOĞLU, Ruth MURRAY, Gabriel ONORATO, Slyvia ARNAVIELHE, Ömer KALAYCI, Jean BOUSQUET, Anna BEDBROOK, Ali Fuat KALYONCU

Türkiye’de mask (Mobile Airways Sentinel networK) allerji günlüğü uygulaması: allerjik rinit ve astımda arıa ile bütünleşmiş mobil teknoloji kullanımı

Akıllı cihazlarda kullanılan aplikasyonlar gibi mobil sağlık (mHealth) uygulamaları, sağlık hizmetlerinde giderek daha yaygınlaşmakta ve daha etkin olmaktadır. Allerjik rinit ve allerjik rinitin astım üzerinde etkisi (ARIA) rehberi kanıta dayalı bulfulara dayanarak hasta yaklaşımları sunan bir rehberden allerjik rinit (AR) ve astımmorbiditesi olan olgularda gerçek yaşamda mobil teknoloji kullanan bir rehber olmaya doğru evrilmiştir. ARIA girişimi olan MASK(Mobile Airways Sentinel networK) allerji günlüğü, hekimler tarafından bu konuda bilgilendirilen kişiler tarafından, ücretsiz olarakinternetten Allergy Diary by MACVIA-ARIA olarak aratılıp, Apple’da App Store, Google’da Play Store’dan indirilebilir. Türkiye’de buaplikasyonun Türkçe validasyonu yapılmış ve kullanılmaya başlanmıştır.

MASK (Mobile Airways Sentinel networK) in Turkey-the ARIA integrated mobile solution for allergic rhinitis and asthma multimorbidity

mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. Allergic Rhinitis and its impact on asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity MASK-rhinitis (Mobile Airways Sentinel networK), the Phase 3 ARIA initiative, is based on the freely available app. The Allergy Diary is used by people who were informed by physicians, searched the internet, Apple App Store, Google Play. Turkish Validation has been available and currently in use.

PDF

___

Bousquet J, Chavannes NH, Guldemond N, Haahtela T, Hellings PW, Sheikh A. Realising the potential of mHealth to improve asthma and allergy care: how to shape the future. Eur Respir J 2017;49.pii:1700447.
Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy 2016;6:47.
Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J 2016;47:1028-33.
Hellings PW, Borrelli D, Pietikainen S, Agache I, Akdis C, Bachert C, et al. European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy 2017;7:49.
Cingi C, Gevaert P, Mösges R, Röndon C, Hox V, Rudenko M, et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy 2017;7:17.
Bousquet J, Schunemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol 2016;138:367-74.e2.
Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy 2015;70:1372-92.
Bousquet J, Onorato GL, Bachert C, Barbolini M, Bedbrook A, Bjermer L, et al. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel Network) Good Practice in allergic rhinitis: a SUNFRAIL report. Clin Transl Allergy 2017;7:37.
Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy 2016;6:29.
Bousquet J, Agache I, Aliberti MR, Angles R, AnnesiMaesano I, Anto JM, et al. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIAARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). Allergy 2018;73:77-92.
Bourret R, Bousquet J, Mercier J, Camuzat T, Bedbrook A, Demoly P, et al. MASK rhinitis, a single tool for integrated care pathways in allergic rhinitis. World Hosp Health Serv 2015;51:36-9.
Klimek L, Bergmann KC, Biedermann T, Bousquet J, Hellings P, Jung K, et al. Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC). Allergo J Int 2017;26:16-24.
Bousquet J, Caimmi DP, Bedbrook A, Bewick M, Hellings PW, Devillier P, et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017;72:857-65.
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63:737-45.
Bousquet J, Bewick M, Arnavielhe S, Mathieu-Dupas E, Murray R, Bedbrook A, et al. Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy 2017;72:1475-84.
Bousquet J, Caimmi D, Bedbrook A, M Bewick, Hellings P, Devillier P, et al. Pilot study of mobile phone technology in allergic rhinitis in European countries. The MASK-rhinitis study. Allergy 2017;72:857-65.
Bousquet J, Arnavielhe S, Bedbrook A, Fonseca J, Morais Almeida M, Todo Bom A, et al. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. Allergy 2018;73:505-10.
Vandenplas O, Vinnikov D, Blanc PD, Agache I, Bachert C, Bewick M, et al. Impact of Rhinitis on Work Productivity: A Systematic Review. J Allergy Clin Immunol Pract 2018;6:1274-86.e9
Anto JM, Bousquet J, Akdis M, Auffray C, Keil T, Momas I, et al. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol 2017;139:388-99.
Garcia-Aymerich J, Benet M, Saeys Y, Pinart M, Basagana X, Smit HA, et al. Phenotyping asthma, rhinitis and eczema in MeDALL population-based birth cohorts: an allergic comorbidity cluster. Allergy 2015;70:973-84.
Bousquet J, Devillier P, Arnavielhe S, Bedbrook A, AlexisAlexandre G, van Eerd M, et al. Treatment of allergic rhinitis using mobile technology with real world data: The MASK observational pilot study. Allergy 2018 Jan 15.
Yorgancioglu A, Türktas H, Kalayci O, Yardim N, Buzgan T, Kocabaş A, et al. The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey). Tuberk Toraks 2009;57:439-52.
Yorgancioglu A, Yardim N, Ergün P, Karlıkaya C, Kocabaş A, Mungan D, et al. Integration of GARD Turkey national program with other non-communicable diseases plans in Turkey. Tuberk Toraks 2010;58:213-28.
Yorgancioglu A, Cruz AA, Bousquet J, Khaltaev N, Mendis S, Chuchalin A, et al. The Global Alliance against Respiratory Diseases (GARD) Country Report. Prim Care Respir J 2014;23:98-101.
Yorgancıoğlu A, Gemicioglu B, Ekinci B, Özkan Z, Bayram H, Ergan B, et al. Asthma in the context of global alliance against respiratory diseases (GARD) in Turkey. J Thorac Dis 2018;10:2052-8.
Yorgancıoğlu A, Kalaycı Ö, Cingi C, Gemicioğlu B, Kalyoncu AF, Agache I, et al. ARIA 2016 yönetici özeti: Yaşam döngüsü boyunca hastalıkları öngörmeye yönelik tıpuygulamaları için bütünleştirilmiş yaklaşım yolakları. Tuberk Toraks 2017;65:32-40.